4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-23-010956
Chief R&D Officer sold 10,484 shares at $3.00 ($31,452)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zalevsky Jonathan Chief R&D Officer | 2023-02-16 | Sale | −10,484 | $3.00 | $31,452 | 303,179 | D |
| Open-market sales · 10,484 sh · avg $3.00 · $31,452 | |||||||
Loading xslF345X03/doc4.xml…